These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30663838)

  • 1. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.
    Marion O; Abravanel F; Izopet J; Kamar N
    Transpl Infect Dis; 2019 Apr; 21(2):e13050. PubMed ID: 30663838
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.
    Marion O; Lhomme S; Del Bello A; Abravanel F; Esposito L; Hébral AL; Lavayssière L; Cointault O; Ribes D; Izopet J; Kamar N
    J Hepatol; 2019 Jan; 70(1):206-209. PubMed ID: 30563687
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
    Sastre L; García-López M; Pérez-Del-Pulgar S; Lens S; Costa J; Navasa M; Forns X
    Gastroenterol Hepatol; 2020 Mar; 43(3):136-137. PubMed ID: 31902599
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
    Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy in chronic hepatitis E: a systematic review.
    Peters van Ton AM; Gevers TJ; Drenth JP
    J Viral Hepat; 2015 Dec; 22(12):965-73. PubMed ID: 25760481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.
    Del Bello A; Guilbeau-Frugier C; Josse AG; Rostaing L; Izopet J; Kamar N
    Transpl Infect Dis; 2015 Apr; 17(2):279-83. PubMed ID: 25708383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient.
    Speers DJ; Ma MX; Faddy HM; Nash M; Bowden S; de Boer B; MacNicholas R; MacQuillan G; Adams L
    Med J Aust; 2015 Mar; 202(4):209-11. PubMed ID: 25716605
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
    Sridhar S; Chan JFW; Yap DYH; Teng JLL; Huang C; Yip CCY; Hung IFN; Tang SCW; Lau SKP; Woo PCY; Yuen KY
    J Viral Hepat; 2018 Feb; 25(2):209-213. PubMed ID: 28984015
    [No Abstract]   [Full Text] [Related]  

  • 14. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment.
    Alric L; Bonnet D; Beynes-Rauzy O; Izopet J; Kamar N
    Am J Gastroenterol; 2011 Aug; 106(8):1562-3. PubMed ID: 21811285
    [No Abstract]   [Full Text] [Related]  

  • 16. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.
    Chaillon A; Sirinelli A; De Muret A; Nicand E; d'Alteroche L; Goudeau A
    J Heart Lung Transplant; 2011 Jul; 30(7):841-3. PubMed ID: 21515077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report.
    Waldenström J; Castedal M; Konar J; Karason K; Lagging M; Norder H
    J Med Case Rep; 2015 Aug; 9():180. PubMed ID: 26307049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.